Skip to main content

Author: Clinton Health Access Initiative (CHAI)


Injectables Access Collaborative brief

This brief describes the work of the Injectables Access Collaborative which provides data-driven technical assistance, coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming. The Access Collaborative is led by PATH in partnership with the Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, and JSI.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2024

Task-sharing: Expanding community access to injectable contraception

The Injectables Access Collaborative Learning and Action Network hosted this webinar on February 28, 2024 highlighting task-sharing provision of injectable contraception—including DMPA-SC and self-injection—through support from community health workers (CHWs). At least 13 countries now authorize CHWs to support clients’ initiation of self-injection at the community level. Participants learned about the latest data on DMPA-SC provision and self-injection support by CHWs, heard from ministry of health representatives and CHWs themselves about the practice and potential of task-sharing of self-care services, and reflected on how to strengthen community health programs to improve equitable access to integrated primary health care services, including an expanded range of family planning options.

This event is part of series on task-sharing along with this webinar on private sector access to DMPA-SC.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI, Community Health Impact Coalition
Publication date: February, 2024

Access Collaborative technical assistance (TA) resource menu

The Access Collaborative provides free data-driven technical assistance (TA), coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming.

In addition to general information and evidence on DMPA-SC, partners can access the support outlined in the menu below by submitting a request through the technical assistance request form, also linked below. Your request can be submitted by emailing the completed form to FPoptions@path.org.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), Jhpiego, JSI, inSupply Health
Publication date: 2024

DMPA-SC Update newsletter

DMPA-SC Update is a periodic newsletter from the Injectables Access Collaborative highlighting global efforts to expand access to the self-injectable DMPA-SC in the context of a full range of family planning options. Click here to subscribe. For more information, please contact FPoptions@path.org.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2024

Self-Injection Ambassador Initiative

Through the Self-injection Ambassadors initiative, the Injectables Access Collaborative (AC) brings together experienced, influential individuals who can elevate the evidence-based potential of self-injection in their daily work and through new opportunities facilitated by the AC. In addition to acting as resources for countries undertaking the self-injection journey, Ambassadors serve as global advocates on self-injection best practices—engaging donors, normative agencies, and implementing partners as appropriate. More broadly, Ambassadors also champion self-care for sexual and reproductive health. For more information, contact FPoptions@path.org.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2024

DMPA-SC Advocacy Pack

Tools for advocacy and communications to increase contraceptive access and options

DMPA-SC is transforming contraceptive access, use, and choice for women and adolescent girls. Advocates play an important role in making sure their country’s policies and funding support access to a broad method mix, including options like DMPA-SC and self-injection.

The Injectable Access Collaborative’s DMPA-SC Advocacy Pack is designed to accelerate your advocacy efforts. It consists of evidence-based materials for advocates to use both for their own strategy development and for direct advocacy with decision-makers. Available in English and French in PDF, Word, and PowerPoint formats, materials are customizable and unbranded so that you can tailor them to your country context. Advocacy Pack for Subcutaneous DMPA. Product brand name Sayana Press.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: December, 2023

Policy brief template: Scaling-up self-injection of DMPA-SC to increase contraceptive access and options

This customizable DMPA-SC Advocacy Pack template provides a brief description of DMPA-SC; an overview of evidence on how the product expands access through multiple delivery channels; and policy and advocacy recommendations for country decision-makers.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

Recommended actions for advocates to advance DMPA-SC

This DMPA-SC Advocacy Pack brief provides examples of actions that may be useful for advocates seeking to increase access to DMPA-SC, including self-injection.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

DMPA-SC key facts: Answering questions and dispelling common myths

This DMPA-SC Advocacy Pack brief offers concise, evidence-based information to help answer common questions and dispel myths about injectable contraception.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023

The case for DMPA-SC

Using simple messages, this DMPA-SC Advocacy Pack case statement describes reasons why DMPA-SC is a valuable and game-changing addition to a broad contraceptive method mix.

Institutional author(s): PATH, Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, JSI
Publication date: 2023